Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intersect ENT, Inc. - Common Stock (NQ: XENT )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Intersect ENT, Inc. - Common Stock

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Reports Third Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe
From Intersect ENT®, Inc.
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD)... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
INVESTIGATION: Halper Sadeh LLP Investigates NLOK, XENT, NWHM; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: NortonLifeLock Inc. (NASDAQ:NLOK) concerning... 
From Halper Sadeh LLP
Via AccessWire
Topics Fraud
Exposures Legal
INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT
From Kahn Swick & Foti, LLC
Via Business Wire
Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XENT
From Halper Sadeh LLP
Via Business Wire
Intersect ENT Reports Second Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis
From Intersect ENT
Via Business Wire
Intersect ENT to Report Second Quarter 2021 Financial Results on August 6
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Reports First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT to Participate at Upcoming Investor Conferences
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Announces Appointment of New Vice President of Sales
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement
From Intersect ENT, Inc.
Via Business Wire
EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
From Intersect ENT, Inc.
Via Business Wire
Intersect ENT to Report First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.